<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
85996-173-00
</NDCCode>
<PackageDescription>
5 POUCH in 1 CARTON (85996-173-00) / 2.8 g in 1 POUCH
</PackageDescription>
<NDC11Code>
85996-0173-00
</NDC11Code>
<ProductNDC>
85996-173
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Norms Hemorrhoid
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Glycerin, Lidocaine, Petrolatum, Phenylephrine Hcl
</NonProprietaryName>
<DosageFormName>
CREAM
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20250808
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M015
</ApplicationNumber>
<LabelerName>
Totally Normal Company
</LabelerName>
<SubstanceName>
GLYCERIN; LIDOCAINE; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
14.4; 5; 15; .25
</StrengthNumber>
<StrengthUnit>
g/100g; g/100g; g/100g; g/100g
</StrengthUnit>
<Pharm_Classes>
Adrenergic alpha1-Agonists [MoA], Allergens [CS], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Local Anesthesia [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-08-11
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250808
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>